These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28467789)

  • 41. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice.
    Cai ZY; Wang CL; Lu TT; Yang WM
    Curr Mol Med; 2019; 19(5):342-348. PubMed ID: 30873920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The db mutation improves memory in younger mice in a model of Alzheimer's disease.
    Zhang L; Fernandez-Kim SO; Beckett TL; Niedowicz DM; Kohler K; Dasuri K; Bruce-Keller AJ; Murphy MP; Keller JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2157-2167. PubMed ID: 31034991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma rich in growth factors (PRGF-Endoret) reduces neuropathologic hallmarks and improves cognitive functions in an Alzheimer's disease mouse model.
    Anitua E; Pascual C; Antequera D; Bolos M; Padilla S; Orive G; Carro E
    Neurobiol Aging; 2014 Jul; 35(7):1582-95. PubMed ID: 24524966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.
    Ramos-Rodriguez JJ; Infante-Garcia C; Galindo-Gonzalez L; Garcia-Molina Y; Lechuga-Sancho A; Garcia-Alloza M
    Mol Neurobiol; 2016 May; 53(4):2685-97. PubMed ID: 26156287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).
    Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M
    Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease.
    Becerril-Ortega J; Bordji K; Fréret T; Rush T; Buisson A
    Neurobiol Aging; 2014 Oct; 35(10):2288-301. PubMed ID: 24863668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD.
    Wang W; Tanokashira D; Fukui Y; Maruyama M; Kuroiwa C; Saito T; Saido TC; Taguchi A
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice.
    Bodart-Santos V; Pinheiro LS; da Silva-Junior AJ; Froza RL; Ahrens R; Gonçalves RA; Andrade MM; Chen Y; Alcantara CL; Grinberg LT; Leite REP; Ferreira ST; Fraser PE; De Felice FG
    Alzheimers Dement; 2023 Dec; 19(12):5418-5436. PubMed ID: 37204850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium signaling in Alzheimer's disease & therapies.
    Tong BC; Wu AJ; Li M; Cheung KH
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice.
    Zhang MY; Zheng CY; Zou MM; Zhu JW; Zhang Y; Wang J; Liu CF; Li QF; Xiao ZC; Li S; Ma QH; Xu RX
    Neurobiol Aging; 2014 Dec; 35(12):2713-2725. PubMed ID: 25044076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative Gene-Expression Analysis of Alzheimer's Disease Progression with Aging in Transgenic Mouse Model.
    Abid NB; Naseer MI; Kim MO
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum amyloid A1 is involved in amyloid plaque aggregation and memory decline in amyloid beta abundant condition.
    Jang S; Jang WY; Choi M; Lee J; Kwon W; Yi J; Park SJ; Yoon D; Lee S; Kim MO; Ryoo ZY
    Transgenic Res; 2019 Dec; 28(5-6):499-508. PubMed ID: 31407125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    Cai HY; Yang D; Qiao J; Yang JT; Wang ZJ; Wu MN; Qi JS; Hölscher C
    J Alzheimers Dis; 2021; 83(2):799-818. PubMed ID: 34366339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
    Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
    Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.
    Jiao SS; Yao XQ; Liu YH; Wang QH; Zeng F; Lu JJ; Liu J; Zhu C; Shen LL; Liu CH; Wang YR; Zeng GH; Parikh A; Chen J; Liang CR; Xiang Y; Bu XL; Deng J; Li J; Xu J; Zeng YQ; Xu X; Xu HW; Zhong JH; Zhou HD; Zhou XF; Wang YJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5225-30. PubMed ID: 25847999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.